Onderzoeker
Jo Caers
- Onderzoeksexpertise:
- Basic & translational research
- Trefwoorden:Geneeskunde
- Disciplines:Humane wetenschappen en de kunsten, Ingenieurswetenschappen en technologie, Natuurwetenschappen
- Gebruikers van onderzoeksexpertise:
- Basic & translational research
Affiliaties
- Hematologie (Onderzoeksgroep)
Lid
Vanaf1 jan 2004 → 30 sep 2009 - Immunologie en Microbiologie (Departement)
Lid
Vanaf1 okt 2003 → 30 sep 2007
Publicaties
1 - 10 van 10
- Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Auteurs: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pagina's: 20476-20489 - Molecular mechanisms, current management and next generation therapy in myeloma bone disease(2018)
Auteurs: Roy Heusschen, Joséphine Muller, Elodie Duray, Nadia Withofs, Arnold Bolomsky, Frédéric Baron, Yves Beguin, Eline Menu, Heinz Ludwig, Jo Caers
Pagina's: 14-28 - SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma(2016)
Auteurs: Roy Heusschen, Joséphine Muller, Marilene Binsfeld, Caroline Marty, Erwan Plougonven, Sophie Dubois, Nadia Mahli, Karen Moermans, Geert Carmeliet, Angélique Léonard, et al.
Pagina's: 30712-30729 - The Effects of Forodesine in Murine and Human Multiple Myeloma Cells(2010)
Auteurs: Liesbeth Bieghs, Jo Caers, E Van Valckenborgh, Foina Higginbotham
Pagina's: 1-8 - The Belgian 2010 consensus recommendations for the treatment of Multiple Myeloma(2010)
Auteurs: M. Delforge, M. Andre, G. Bries, Jo Caers, H. Demuynck, B. De Prijck, H. De Samblanx, A. Kentos, N. Meuleman, Fritz Offner, et al.
Pagina's: 252-264 - Thymosin β4 in multiple myeloma: friend or foe(2010)
Auteurs: Jo Caers, Eleonore Otjacques, D. Hose, Bernard Klein
Pagina's: 125-129 - Thymosin {beta}4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.(2010)
Auteurs: Jo Caers, D. Hose, Ine Kuipers, Tomas Bos, E Van Valckenborgh, Eline Menu, Elke De Bruyne, Hartmut Goldschmidt, Benjamin Van Camp, Bernard Klein, et al.
Pagina's: 163-167 - Multiple Myeloma, an update on diagnosis and treatment(2008)
Auteurs: Jo Caers, Isabelle Vande Broek, L Michaux, Fabienne Trullemans, Benjamin Van Camp
Pagina's: 329-343 - Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma(2008)
Auteurs: Jo Caers, Doreen Lepage, E Van Valckenborgh, Benjamin Van Camp, Enrique Alvarez
Pagina's: 1966-1974 - Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding microenvironment.(2008)
Auteurs: Jo Caers, E Van Valckenborgh, Benjamin Van Camp
Pagina's: 301-313